Day 2 of the event saw the focus shift from Agri to stems and innovation
The second day of the 15th edition of Bangalore India BIO was dotted with several thought provoking session addressed by key influencers from the industry. The day was dedicated to deliberations on research, diagnostics & collaborations that would create new pathways. There were a few session on Agribiotech that explored the nuances of bioenergy and value addition in agriculture.
The Agribiotech Inaugural Session opened with a keynote addressal by Mr Jagadish Patankar stressing on the fact that Biotech has a much larger role to play than just healing the world. Dr KK Narayanan inaugurated the maiden session of the day by giving an overview of what the day has to offer. Dr M Mahadevappa, director (Rural Development), JSSMVP, then went to elaborate on the importance of innovative technology in agriculture and how it can provide tangible solutions to the problems being faced today. Mr Srivatsa Krishna, secretary to Government, Department of IT, BT and S&T and DPAR (e-Governance) Government of Karnataka also shared his vision of taking Bangalore India BIO to a global level next year.Bio Medical Innovations and Diagnostics was attended by organizations like, InnAccel Acceleration Services, Johnson & Johnson Innovation Center, HTIC IIT Madras, Medtronic. The panel shared the best practices and highlighted how the innovation that they have adopted has helped the healthcare sector in India.
The Commercialization of Stem Cells: Promises & Public Concerns session was one of the key highlights of the day. Sharing an insight into the evolution of stem cell therapy, Mr Mohan C Vemuri spoke of how the sector has seen major development over the last 14 years. He spoke of how stem cell therapy can help address cardiovascular, orthopedic & inflammatory diseases. The therapy can also be helpful for cancer treatment, allergen response, etc. He ended his addressal on a hopeful note stating that if we advance at this rate, treatment for the same can be made available to general public within the next 20 years. Dr Christian Van Den Bos, spoke about the aspect of commercialization of stem cell therapy and how regulatory frame work can aid the research by tweaking the guidelines a bit.
Dr Sanjay Desai, surgeon and professor, MS Ramaiah Medical College and Hospital spoke how stem cell therapy can emerge as the standard for medical care in the future given its non-invasive nature.